Login
$ENTA
$11.20 +$0.53 (4.97%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Tara L. Kieffer
Chief Operating Officer
48 Not stated 2020 Not reported
Yat Sun Or
Chief Scientific Officer
74 Since 1999
27 years
Not stated $1,293,790
Scott T. Rottinghaus
Chief Medical Officer
52 Since 2022
4 years
Not stated $1,343,212
Matthew P. Kowalsky
Chief Legal Officer and Corporate Secretary
53 Not stated Not stated Not reported
Brendan Luu
Chief Business Officer
51 Since 2024
2 years
2021 Not reported
Harry R. Trout III
Vice President, Finance (Principal Financial Officer)
57 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
11.6 years
from year joined
CEO also chairs the board
No
Bruce L.A. Carter
Director Age On board Independent Committees Other public boards 2025 pay Source
Bruce L.A. Carter
82 2013
13 years
Independent
Compensation
None stated Not stated
Jay R. Luly
69 2003
23 years
Not independent None stated None stated Paid as CEO
Yujiro S. Hata
51 2021
5 years
Independent
Compensation
None stated $123,832
Kristine Peterson
66 2017
9 years
Independent
Compensation · Chair
Immunocore, plc, ArriVent BioPharma, Inc. $131,332
Terry C. Vance
69 2011
15 years
Independent
Nominating and Corporate Governance · Chair
None stated $138,832
Mark G. Foletta
65 2020
6 years
Independent
Audit · Chair
DexCom, Inc., AMN Healthcare Services, Inc. $136,332
Lesley Russell
65 2016
10 years
Independent
Audit
Imugene Limited, Chimeric Therapeutics Limited Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jan 26, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support